A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
Clinical trial NCT02973711 · WITHDRAWN
Trial details
- NCT number
- NCT02973711
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2021-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.